XTL Biopharmaceuticals Ltd. (XTLB) rose 42.02% or 0.71 to $2.4. It is around 1.90 million shares traded, which is 26969.52% compare to the average total volume 7044. The market cap of XTLB is $12.34 million. The year to date change is -30.74%. The 52 week price range is from $1.55 to $4.14. Price of XTLB have changed 9.02% during last week. It have changed -3.51% over last month, -17.16% over last 3 months, -29.59% over last 6 months and -35.50% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XTLB is 1.73. It is -27.92% below current price. The 200-day Moving Averages for XTLB is 2.32. It is -3.33% below current price. The 52-week High is 4.14. It is 72.50% from the current price. The 52-week Low is 1.55. It is -35.42% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of XTLB is 5.15 on 2018-04-13. Short % to float is 1.12%. There are some statistics of XTLB. It is has market cap $12.34 million. The share outstanding is 5.14 million. The average volume is 7044. The percent of top 15 Institution holding is 0.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XTLB is -23.37%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XTLB is -15.58%.